James Lindsay
0000-0002-6295-098X
Dana Farber Cancer Institute
5 papers found
Refreshing results…
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non–Small Cell Lung Cancer
Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer
Network for biomarker immunoprofiling for cancer immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network
Missing publications? Search for publications with a matching author name.